Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Short courses of systemic steroids effective in severe chronic obstructive pulmonary disease
Vault Navigation
Short courses of systemic steroids effective in severe chronic obstructive pulmonary disease
How effective are short (7 or fewer days) compared with longer (more than 7 days) courses of systemic corticosteroids for exacerbations of chronic obstructive pulmonary disease (COPD)?
People treated with short courses did not have a higher rate of treatment failure or longer time to their next exacerbation. Times in hospital and lung function at the end of treatment were not different. No differences in side effects or death were noted between treatments. Information on quality of life was limited, as only 1 study measured it.
The studies did not include people with mild or moderate COPD. Most evidence was graded as having moderate quality as the result of imprecision. For example, many studies did not provide details of their inclusion criteria, including their definition of an acute exacerbation of COPD, and duration of follow-up varied between studies and was not stated in 4 studies.
Current guidelines recommend patients with acute exacerbations of COPD should be treated with systemic corticosteroids for 7-14 days. Intermittent systemic corticosteroid use is cumulatively associated with adverse effects such as osteoporosis, hyperglycaemia and muscle weakness. Shorter treatment could reduce adverse effects.
Walters JAE et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Reviews, 2014, Issue 12. Art. No.: CD006897.DOI: 10.1002/14651858. CD006897.pub3. This review contains 8 studies involving 582 participants.
Cochrane Systematic Reviews for primary care practitioners
Developed by the Cochrane Primary Care Field, New Zealand Branch of the Australasian Cochrane Centre at the Department of General Practice and Primary Health Care, University of Auckland and funded by the Ministry of Health and New Zealand Doctor. PEARLS are meant for educational use and not to guide clinical care. New Zealanders can access the Cochrane Library free via www.cochrane.org.nz